Profile: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

28.40EUR
19 Dec 2014
Price Change (% chg)

€0.63 (+2.29%)
Prev Close
€27.76
Open
€27.50
Day's High
€28.71
Day's Low
€27.50
Volume
57,981
Avg. Vol
69,628
52-wk High
€34.60
52-wk Low
€22.60

Search Stocks
Grifols SA is a Spain-based company engaged in the healthcare sector. The Company is involved in the research, development, manufacturing and marketing of medical solutions for hospitals, which include plasma-derived therapies, as well as diagnosis and pharmaceutical products. Its activities are structured in five segments: Bioscience, which focuses on the research for obtaining new therapies and solutions aimed at patients who suffer from illnesses stemming from plasma deficits; Diagnostic, which comprises the research, development and marketing of diagnostic products for clinical laboratories, Hospital, which offers ready-to-use pharmaceutical preparations and products for clinical nutrition; Technology, which focuses on automation equipment for the hospital sector; and Raw Materials, which includes sales of biological products and services. The Company is a parent of Grupo Grifols.

Company Address

Grifols SA

C/ Jesus i Maria, 6
BARCELONA   BAR   08022
P: +34935.710100
F: +34935.710267

Search Stocks